Hybrid Tetramers of Wild-Type and Amyloidogenic H88R Transthyretin Challenge the Monomer Paradigm
Preprint
Abstract
Hereditary transthyretin amyloidosis (ATTRv) is driven by mutations that destabilize the native tetrameric transthyretin (TTR), promoting monomer formation and amyloid aggregation. The H88R variant has been considered fully monomeric, yet its behavior in heterozygous patients has remained unclear. Here, we demonstrate that H88R TTR can form hybrid tetramers with wild-type chains, both in vitro and in patient sera. We considered all possible tetramers, along with various trimer and dimer constructions, and found that the stability of hybrid tetramers containing one or two mutant chains is not significantly reduced in comparison with of the wild-type tetramer, suggesting a practically unhindered entry for H88R TTR monomers into such hybrid tetrameric assemblies, facilitating their secretion. Mass spectrometry confirms incorporation of H88R chains into tetramers in vitro, and show that the H88R TTR variant is present in the serum of carriers albeit in low concentration. We propose that the scarcity of this variant is the result of its retention in the endoplasmic reticulum and present a model for the association of H88R TTR with the endoplasmic reticule chaperone Binding immunoglobulin Protein (BiP). These findings revise the current monomeric view of H88R TTR, with direct implications for the efficacy of tetramer-stabilizing therapeutics. Our results highlight a delicate balance between cellular retention and hybridization, informing mechanistic understanding and treatment strategies in heterozygous ATTRv patients.Keywords
This publication has 57 references indexed in Scilit:
- Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatmentAmerican Journal of Hematology, 2023
- Modulation of human transthyretin stability by the mutations at histidine 88 studied by free energy simulationProteins: Structure, Function, and Bioinformatics, 2022
- Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatmentAmerican Journal of Hematology, 2022
- Estimating the Gender Distribution of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-AnalysisCardiology and Therapy, 2020
- Stability and crystal structures of His88 mutant human transthyretinsFEBS Letters, 2017
- A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis familyEuropean Journal of Medical Genetics, 2015
- Amyloid-β and TauJAMA Neurology, 2014
- Motional timescale predictions by molecular dynamics simulations: Case study using proline and hydroxyproline sidechain dynamicsProteins: Structure, Function, and Bioinformatics, 2013
- The Biological and Chemical Basis for Tissue-Selective Amyloid DiseaseCell, 2005
- Exploring protein native states and large‐scale conformational changes with a modified generalized born modelProteins: Structure, Function, and Bioinformatics, 2004